[1]Monzavi R, Cohen P.IGFs and IGFBPs∶role in health and disease[J].Best Pract Res Clin Endocrinol Metab, 2002, 16 (3) ∶433-447.
|
[2]吴云林, 叶静, 张曙, 等.肝硬化患者血清胰岛素样生长因子及其结合蛋白测定与肝功能状况的关系[J].中华消化杂志, 2002, 22 (10) ∶601-604.
|
[3]Sidlova K, Pechova M, Akotaska K, et al.Insulin-like growth factorbinding protein-3 in patients with liver cirrhosis[J].Physiol Res, 2002, 51 (6) ∶587-90.
|
[4]Shaarawy M, Fikry MA, Massoud BA, et al.Insulin-like growth factorbinding protein-3∶a novel biomarker for the assessment of the syntheticcapacity of hepatocytes in liver cirrhosis[J].J Clin Endocrinol Metab, 1998, 83 (9) ∶3316-9.
|
[5] 中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) ∶324-329.
|
[6]Weber MM, Auernhammer CJ, Lee PD, et al.Insulin-like growth fac-tors and insulin-like growth factor binding proteins in adult patients withsevere liver disease before and after orthotopic liver transplantation[J].Horm Res, 2002, 57 (3-4) ∶105-12.
|
[7]Schalch DS, Kalayoglu M, Pirsch JD, et al.Serum insulin-like growthfactors and their binding proteins in patients with hepatic failure and afterliver transplantation[J].Metabolism, 1998, 47 (2) ∶200-6.
|
[8]Ottesen LH, Bendtsen F, Flyvbjerg A.The insulin-like growth factorbinding protein 3 ternary complex is reduced in cirrhosis[J].Liver, 2001, 21 (5) ∶350-6.
|
[9]Donaghy AJ, Delhanty PJ, Ho KK, et al.Regulation of the growth hor-mone receptor/binding protein, insulin-like growth factor ternary com-plex system in human cirrhosis[J].J Hepatol, 2002, 36 (6) ∶751-8.
|
[10]Wallace JD, Abbott-Johnson WJ, Crawford DH, et al.GH treatmentin adults with chronic liver disease:a randomized, double-blind, placebo-controlled, cross-over study[J].J Clin Endocrinol Metab, 2002, 87 (6) ∶2751-9.
|
[11]郭新会, 陈义森, 金荣华, 等.重组人生长激素治疗肝炎后肝硬化患者低蛋白血症的实验与临床研究[J].中华实验和临床毒学杂志, 2001.15 (4) ∶339-341.
|
[1] | Hu Yan, Wan Jie, Ou YangShaoXia. Role of serum interleukin-12 and tumor necrosis factor on human viral hepatitis.[J]. Journal of Clinical Hepatology, 2007, 23(5): 353-355. |
[2] | Chen Sheng, Lin ChaoShuang. The relationship between liver function and immune system and viral replication in patients with viral hepatitis[J]. Journal of Clinical Hepatology, 2007, 23(2): 94-95. |
[3] | Yang JinHui, Li XiangJin. Serum C3、C4 levels in patients with hepatitis B[J]. Journal of Clinical Hepatology, 2007, 23(5): 355-356. |
[4] | Tao Hu, Gao Tao, Xu Bin. Revaluate the clinical significance of serum transferrin changes in patients with hepatitis[J]. Journal of Clinical Hepatology, 2004, 20(3): 148-149. |
[6] | Zhang LiaoYun, Li DeHua, Zhang LingRong, Wang ShouYi. The study of the level of serum soluble interleukin 2 receptor in patients with viral hepatitis E.[J]. Journal of Clinical Hepatology, 2001, 17(2): 87-88. |
[8] | He DongGou, Chen BoMing, Lin YongPing. Research of T lymphocyte subtypes and the phagocytosis activity of macrophages in the patients with virul hepatitis[J]. Journal of Clinical Hepatology, 2000, 16(1): 30-31. |
[9] | Zhang Min, Zhang LingXia, Xin ShaoJie, Zhao JingMin, Wang SongShan, Wang LinJie. The relationship between transforming growth factor β1 and liver fibrosis[J]. Journal of Clinical Hepatology, 2000, 16(1): 32-33. |